|
Index of reports
> Cases resulting in life threatening events (42)
> Cases with Dyspnoea (14)
Below is the selection of adverse event reports related to Voltaren (Diclofenac) that includes cases resulting in life threatening events where reactions include dyspnoea.
Adverse event in 56 year old female receiving Voltaren (Diclofenac)
Reported by a physician from Norway on 2007-10-24
Patient: 56 year old female
Adverse reactions / side effects: Dyspnoea, Hyponatraemia, Obstructive Airways Disorder, Generalised Oedema
Adverse event resulted in: life threatening event
Suspect drug(s):
Ibux
Indication: Arthralgia
Start date: 2007-08-01
Naproxen
Administration route: Oral
Indication: Arthralgia
Cozaar
Dosage: 1 df, qd
Administration route: Oral
Indication: Hypertension
Diural
Dosage: 40 mg, qd
Administration route: Oral
Indication: Oedema
Start date: 2007-08-28
Brexidol
Administration route: Oral
Indication: Arthralgia
Voltaren
Dosage: 50 mg, tid
Administration route: Oral
Indication: Arthralgia
Start date: 2007-08-01
Other drugs received by patient: Pinex Forte; Doxylin; Vival; Noni Juice; Pinex; Fenazon-Koffein
Adverse event in 60 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-10-02
Patient: 60 year old male, weighing 62.0 kg (136.4 pounds)
Adverse reactions / side effects: Intermittent Positive Pressure Breathing, Pco2 Decreased, Dyspnoea, Stridor, Hypercapnia, Blood PH Decreased, Status Asthmaticus, Japan Coma Scale Abnormal, Altered State of Consciousness, Cough
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren
Dosage: 50 mg/day
Indication: Neck Pain
Start date: 2007-02-14
Voltaren
Dosage: 50 mg/day
Start date: 2007-02-14
Adverse event in 60 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-10-02
Patient: 60 year old male, weighing 62.0 kg (136.4 pounds)
Adverse reactions / side effects: Intermittent Positive Pressure Breathing, Pco2 Decreased, Dyspnoea, Stridor, Hypercapnia, Blood PH Decreased, Status Asthmaticus, Japan Coma Scale Abnormal, Altered State of Consciousness, Cough
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren
Dosage: 50 mg/day
Indication: Neck Pain
Start date: 2007-02-14
Voltaren
Dosage: 50 mg/day
Start date: 2007-02-14
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-07-16
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Drug Eruption, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Erythema, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Lymphocyte Count Decreased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Blood Urea Increased, Dyspnoea, Neutrophil Count Increased, Monocyte Count Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in 69 year old male receiving Voltaren (Diclofenac)
Reported by a consumer/non-health professional from Italy on 2007-07-05
Patient: 69 year old male
Adverse reactions / side effects: Defaecation Urgency, Dyspnoea, Swollen Tongue, Laryngeal Oedema, Feeling Abnormal, Hyperhidrosis, Paraesthesia
Adverse event resulted in: life threatening event
Suspect drug(s):
Calcium Chloride
Voltaren
Indication: Musculoskeletal Chest Pain
Start date: 2007-04-09
Voltaren
Dosage: 50 mg, unk
Start date: 2007-06-29
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-29
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Erythema, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Lymphocyte Count Decreased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Monocyte Count Decreased, Neutrophil Count Increased, Blood Urea Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-19
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Oxygen Saturation Decreased, Lymphocyte Count Decreased, White Blood Cell Count Increased, Neutrophil Count Increased, Blood Urea Increased, Dyspnoea, Monocyte Count Decreased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in 29 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Australia on 2007-06-14
Patient: 29 year old female
Adverse reactions / side effects: Eyelid Oedema, Dyspnoea, Tachycardia, Respiratory Distress
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren (Diclofenac)
Adverse event in 11 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-07
Patient: 11 year old male, weighing 32.0 kg (70.4 pounds)
Adverse reactions / side effects: Blood PH Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Petechiae, Pyrexia, Erythema, Blood Fibrinogen Decreased, Interstitial Lung Disease, C-Reactive Protein Increased, Acute Respiratory Distress Syndrome, Blood Creatinine Increased, White Blood Cell Count Increased, Cough, Renal Failure Acute, Hypertensive Encephalopathy, Dyspnoea, Blood Urea Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Pancytopenia, Life Support, Rash, Protein Total Decreased, Lymphocyte Stimulation Test Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, PO2 Increased, Lung Infiltration, Calculus Ureteric
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Predonine; Bufferin; Sulpyrine; Kashilon; Cefazolin Sodium; Methylprednisolone 16mg TAB
Adverse event in 11 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-04
Patient: 11 year old male, weighing 32.0 kg (70.4 pounds)
Adverse reactions / side effects: Blood PH Increased, Disseminated Intravascular Coagulation, Petechiae, Blood Albumin Decreased, Blood Fibrinogen Decreased, C-Reactive Protein Increased, Acute Respiratory Distress Syndrome, Blood Creatinine Increased, White Blood Cell Count Increased, Renal Failure Acute, Cough, Dyspnoea, Blood Urea Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Pancytopenia, Protein Total Decreased, Lymphocyte Stimulation Test Positive, Rash, Aspartate Aminotransferase Increased, Platelet Count Decreased, PO2 Increased, Lung Infiltration, Calculus Ureteric
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Predonine; Bufferin; Sulpyrine; Kashilon; Cefazolin Sodium
Adverse event in 49 year old female receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-05-22
Patient: 49 year old female
Adverse reactions / side effects: Dyspnoea, Stridor, Feeling Hot, Anaphylactic Shock, Drug Interaction, Blood Glucose Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren
Dosage: unk, unk
Administration route: Oral
Indication: Herpes Zoster
Start date: 2007-05-07
End date: 2007-05-07
Valtrex
Dosage: unk, unk
Administration route: Oral
Indication: Herpes Zoster
Start date: 2007-05-07
Other drugs received by patient: Neuer; Cyanocobalamin
Adverse event in 41 year old male receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-05-11
Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol
Adverse event in 41 year old male receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-04-06
Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol
Adverse event in 41 year old male receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-03-16
Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol
|
